PR Firm | Public Relations | Public Affairs – The Publicity Agency

Diffusion Pharmaceuticals Tackles Big Pharma on Recalculating

It’s a tale as old as time, beginning with David and Goliath to today’s Diffusion Pharmaceuticals and “The Big Guys.” Chief Science Officer and co-founder, John Gainer, went on Recalculating to talk about his journey from University of Virginia professor to pioneer in treatments and therapies for cancer, hypoxia and numerous other diseases and conditions. This product has been in the works since 2001 and is making its way to clinical trial. During recent tests, John said “we had some people in …for glioblastoma which is a primary brain tumor. It’s usually pretty fatal but we’ve have had people writing back saying thank you for giving my life back.” For those interested in the treatment itself or what it’s like to take on industry titans as a small business executive, this episode can’t be missed.

Over the last few months, The Publicity Agency has been helping John Gainer and Diffusion Pharmaceuticals get its story into the world. It doesn’t just create awareness for medical breakthroughs, it shows the power of small business in areas many wouldn’t dare try to compete. Our team has worked endlessly to call attention to the Diffusion story, and this won’t be the last you hear of it.

Diffusion Pharmaceuticals is a clinical stage company which developed a drug to help many different diseases by increasing the amount of oxygen within treatment resistant tissue. This allows the cells to become more vulnerable to treatment such as chemotherapy and radiation.


Full interview:

pixelstats trackingpixel